International Isotopes shuffles management team

Article

Following the retirement of chairman and treasurer Ira Lon Morgan, radiopharmaceutical manufacturer International Isotopes has made some additional changes to its senior management team (SCAN 12/15/99). The Denton, TX-based company, which is in

Following the retirement of chairman and treasurer Ira Lon Morgan, radiopharmaceutical manufacturer International Isotopes has made some additional changes to its senior management team (SCAN 12/15/99). The Denton, TX-based company, which is in the process of transitioning to fully commercial operations, announced that newly appointed CEO David Camp has taken on the additional responsibilities of president. Camp replaces former president Carl Seidel, who has left the company.

In addition, Bryce Drake has joined International Isotopes as director of support services. Drake takes over the position from George Butterworth, who has stepped into the new position of director of radioisotope production. Also new to the management team is Scott Colpitts, who has replaced Gaylord King as director of radiopharmaceutical manufacturing. King will continue to work closely with the firm.

In other company news, the Bureau of Radiation Control of the Texas Department of Health approved amendments to International Isotopes’ operational and development licenses that will allow the company to produce commercial quantities of radioisotopes for use in nuclear medicine procedures.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.